Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Novartis Ups Fluvirin Supply in U.S. | Contract Pharma
Breaking News

Novartis Ups Fluvirin Supply in U.S.

Novartis Vaccines will increase the supply of its Fluvirin vaccine 30% for distribution in the U.S. during the 2007-2008 flu season and plans to produce approximately 40 million doses. Based on accelerated production plans, half of these doses are planned for September delivery, with all doses expected to be delivered by the end of October, depending on the release of doses by the FDA.  
   
“Providing a reliable and timely supply of flu vaccines is a top priority for Novartis in supporting U.S. public health goals of increasing vaccination rates among the growing number of people at risk and recommended for vaccination,” said Rajiv De Silva, president of Novartis Vaccines in the U.S.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters